| Ticker Symbol | Entity Name | Form Type | Access Number | Period | As Of Date | Filing Date | Institution Name | CIK | Name of Issuer | Title of Class | CUSIP | Value | SHRS or PRN Amount | SHRS or PRN Type | PUT_CALL | Investment Discretion | Other Manager | Voting Authority Sole | Voting Authority Shared | Voting Authority None | Date Added | Date Updated | Company Name | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | SERES THERAPEUTICS INC | COM | 81750R102 | 1 | 172 | SH | DFND | 02 | 0 | 0 | 172 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001567619-22-010822 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BANK OF AMERICA CORP /DE/ | 70858 | SERES THERAPEUTICS INC | COM | 81750R102 | 608 | 85369 | SH | DFND | 01 | 29416 | 55953 | 0 | May 17th, 2022 01:54AM | May 17th, 2022 01:54AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001567619-22-010754 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Soviero Asset Management, LP | 1755622 | SERES THERAPEUTICS INC | COM | 81750R102 | 2563 | 360000 | SH | SOLE | 360000 | 0 | 0 | May 17th, 2022 01:53AM | May 17th, 2022 01:53AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001567619-22-010624 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Graham Capital Management, L.P. | 1315421 | SERES THERAPEUTICS INC | CO | 81750R102 | 764 | 107388 | SH | SOLE | 107388 | 0 | 0 | May 17th, 2022 01:52AM | May 17th, 2022 01:52AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001567619-22-010575 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1021223 | SERES THERAPEUTICS | COMMON | 81750R102 | 2 | 247 | SH | SOLE | 247 | 0 | 0 | May 17th, 2022 01:52AM | May 17th, 2022 01:52AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001564702-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | PDT Partners, LLC | 1564702 | SERES THERAPEUTICS INC | COM | 81750R102 | 1275 | 179003 | SH | SOLE | 179003 | 0 | 0 | May 17th, 2022 01:52AM | May 17th, 2022 01:52AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001493152-22-013621 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | BOOTHBAY FUND MANAGEMENT, LLC | 1549230 | SERES THERAPEUTICS INC | COM | 81750R102 | 620 | 87067 | SH | OTR | 0 | 87067 | 0 | May 17th, 2022 01:52AM | May 17th, 2022 01:52AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001475597-22-000010 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | HRT FINANCIAL LP | 1475597 | SERES THERAPEUTICS INC | COM | 81750R102 | 274 | 38596 | SH | DFND | 38596 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001454984-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | Ensign Peak Advisors, Inc | 1454984 | Seres Therapeutics Inc | COM | 81750R102 | 219 | 30780 | SH | SOLE | 30780 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||
| nasdaq:mcrb | nasdaq:mcrb Shareholders | 13F-HR | 0001446194-22-000004 | Mar 31st, 2022 12:00AM | May 16th, 2022 12:00AM | May 16th, 2022 12:00AM | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1446194 | SERES THERAPEUTICS INC | COM | 81750R102 | 641 | 90000 | SH | Call | DFND | 2 | 0 | 0 | 0 | May 17th, 2022 01:51AM | May 17th, 2022 01:51AM | Seres Therapeutics | Health Care | Pharmaceuticals & Biotechnology |